Clinical trial

Risk Stratification of Heart Failure in Cardiomyopathies.

NCT02941315

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-12-01

PhasePHASE1

Study timeline

Study start (actual)2016-12-01Date precision: day

Registry last updated2023-06-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cardiomyopathy With Unknown Etiologyunresolved

Interventions

etiologic treatment,anti-myocardial remodelingDRUG

anti-myocardial remodelingDRUG

anti-myocardial remodeling,anti-acute heart failureDRUG

Etiological, anti-remodeling and symptom treatmentDRUG

Sponsors & collaborators

RenJi Hospitallead sponsor

Ruijin Hospitalcollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02941315 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.